PCV54 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS AGED OVER 75 YEARS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY
Abstract
Authors
S Wolowacz N Roskell J Plumb A Clemens P Robinson G Dolan I Brenkel